Chemed Co. (NYSE:CHE) Shares Acquired by Bessemer Group Inc.

Bessemer Group Inc. increased its holdings in shares of Chemed Co. (NYSE:CHE) by 16.2% in the fourth quarter, Holdings Channel reports. The firm owned 832 shares of the company’s stock after buying an additional 116 shares during the quarter. Bessemer Group Inc.’s holdings in Chemed were worth $440,000 as of its most recent filing with the Securities and Exchange Commission (SEC).

Several other hedge funds and other institutional investors also recently bought and sold shares of the business. UMB Bank n.a. boosted its stake in shares of Chemed by 300.0% during the fourth quarter. UMB Bank n.a. now owns 52 shares of the company’s stock worth $28,000 after buying an additional 39 shares during the period. Atala Financial Inc purchased a new stake in Chemed during the 4th quarter valued at approximately $29,000. CBIZ Investment Advisory Services LLC lifted its position in Chemed by 64.7% during the 4th quarter. CBIZ Investment Advisory Services LLC now owns 56 shares of the company’s stock worth $30,000 after acquiring an additional 22 shares during the period. Trust Co. of Vermont purchased a new position in shares of Chemed in the 4th quarter valued at approximately $34,000. Finally, Tortoise Investment Management LLC increased its holdings in shares of Chemed by 77.3% in the fourth quarter. Tortoise Investment Management LLC now owns 78 shares of the company’s stock valued at $41,000 after purchasing an additional 34 shares during the period. 95.85% of the stock is owned by hedge funds and other institutional investors.

Wall Street Analyst Weigh In

Several brokerages have issued reports on CHE. StockNews.com raised shares of Chemed from a “hold” rating to a “buy” rating in a research note on Friday, March 7th. Royal Bank of Canada increased their price target on shares of Chemed from $633.00 to $667.00 and gave the stock an “outperform” rating in a report on Friday, March 14th.

Chemed Price Performance

Chemed stock opened at $588.27 on Wednesday. The stock’s 50 day moving average price is $584.60 and its 200 day moving average price is $567.87. Chemed Co. has a 1-year low of $512.12 and a 1-year high of $623.61. The company has a market cap of $8.60 billion, a PE ratio of 29.73, a price-to-earnings-growth ratio of 2.15 and a beta of 0.49.

Chemed Announces Dividend

The business also recently announced a quarterly dividend, which was paid on Friday, March 14th. Shareholders of record on Monday, February 24th were given a dividend of $0.50 per share. The ex-dividend date was Monday, February 24th. This represents a $2.00 annualized dividend and a dividend yield of 0.34%. Chemed’s payout ratio is currently 10.05%.

Insider Transactions at Chemed

In related news, CEO Kevin J. Mcnamara sold 1,000 shares of the business’s stock in a transaction dated Monday, March 31st. The shares were sold at an average price of $615.33, for a total transaction of $615,330.00. Following the sale, the chief executive officer now owns 101,679 shares of the company’s stock, valued at approximately $62,566,139.07. The trade was a 0.97 % decrease in their ownership of the stock. The transaction was disclosed in a filing with the Securities & Exchange Commission, which is available at this link. Corporate insiders own 3.32% of the company’s stock.

About Chemed

Chemed Corporation provides hospice and palliative care services to patients through a network of physicians, registered nurses, home health aides, social workers, clergy, and volunteers primarily in the United States. The company operates in VITAS and Roto-Rooter segments. It offers plumbing, drain cleaning, excavation, water restoration, and other related services to residential and commercial customers through company-owned branches, independent contractors, and franchisees.